StockData
AgomAb Therapeutics NV logo

AgomAb Therapeutics NV (AGMB) stock

AGMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 23, 2026Score 2/30
$5.62−0.20 (-3.44%)

Close on Nov 19, 2026Market cap $140.50KP/E –Yield –

AgomAb Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

AgomAb Therapeutics's market cap was $174.75K on Nov 11, 2026.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$174.75K–

More AgomAb Therapeutics figures

See a number that looks wrong?